Evaluation of the Impact of the AVanCer Program Provided by the ARRPAC Day Center
NCT ID: NCT05795686
Last Updated: 2024-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
162 participants
INTERVENTIONAL
2023-06-20
2026-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
These events are brutal and their physical, psychological, emotional, social and financial consequences disrupt the lives of patients and their families. Thanks to improved access to thrombolysis and thrombectomy for the management of acute stroke, the prognosis has been profoundly improved. Nevertheless, the increase in post-stroke survival and the evolution of the type of after-effects require the development of support systems dedicated to these post-stroke patients. The same issues are raised for people who have suffered a head injury with similar consequences that require specialised care.
Currently, health care is well structured for the acute phase and there is an improvement in the provision of care in specialised rehabilitation services, but the dedicated medico-social provision for people returning home remains insufficient despite the significant needs. The ARRPAC association (Accompaniment, Rehabilitation, Respite after Stroke and Cerebral Palsy) is setting up a new comprehensive medico-social support programme in Lyon (AVanCer programme, opening in June 2022) to improve the autonomy and adaptation capacities of patients and to relieve the social and psycho-affective burden of carers. This experimental day centre, which complements functional rehabilitation and recurrence prevention care, offers adults with brain injury sequelae and their carers therapeutic education programmes, adapted physical activity, social and cognitive remediation and therapeutic workshops, as well as a place for patients and their carers to exchange information and listen. To achieve its ambition, ARRPAC and the AVanCer programme must be integrated into the existing support offer, create partnerships with care structures and evaluate its added value to ensure its sustainability. In case of efficiency and demonstrated benefits for patients, carers and the health system, such a structure could be deployed in other territories.
This study evaluates the implementation of the AVanCer programme in terms of its effect on the target audience, participants' experience and implementation according to the REAIM evaluative framework (Reach, Effectiveness, Adoption, Implementation, and Maintenance).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of the Performance of Stroke Management in the Rhône Area
NCT02596607
Cohort of Ischemic STROKE Patients
NCT03149705
Impact Of A Training Program And Organization On The Management Of Stroke In The Acute Phase (AVC-II)
NCT02814760
Minor Stroke Therapy Evaluation
NCT03796468
The Experiences of Family Caregivers of Stroke Patients: A Cross-sectional Study of a French Cohort
NCT04741451
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
* Qualitative approach by semi-structured interviews with professionals of the structure
For patients:
* At inclusion:collection of socio-demographic and medical data,Quality of life (QoL) questionnaires,anxiety and depression,autonomy in health,adherence to treatment
* At end of the program:QoL questionnaires,anxiety and depression,autonomy,autonomy in health,adherence to treatment,satisfaction,semi-structured interviews
* 6 months post-program:data on retention and re-hospitalization,QoL questionnaires,anxiety and depression,autonomy in health,adherence to treatment
For caregivers:
* At inclusion:collection of socio-demographic data,QoL questionnaires,anxiety and depression,perceived burden
* At the end of the program:QoL questionnaires,anxiety and depression,perceived burden,semi-structured interviews
* 6 months post-program:data about new support,QoL questionnaires,anxiety and depression,perceived burden
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients of program "AVanCer"
Patients included in program "AVanCer"
Evaluation of program "AVanCer"
Evaluation of program AVanCer with quantitative and qualitative approaches
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Evaluation of program "AVanCer"
Evaluation of program AVanCer with quantitative and qualitative approaches
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female of legal age
* Patient who has been selected to start the AVanCer program at the ARRPAC center
* Patient who has agreed to participate in the PATIENT assessment component and has signed the consent form
* Patient able to speak and understand French both orally and in writing
For caregivers :
* Male or female of legal age
* Person who has agreed to participate in the CAREGIVING assessment component and has signed the consent form
* Person able to speak and understand French both orally and in writing
Population of the qualitative study :
* Voluntary patients and caregivers who participated in the quantitative part (follow-up by questionnaires)
* Partner professionals: a sample of 10 representatives of ARRPAC partners who referred people for support during the first 12 months, from the following structures: public Medicine, Surgery, Obstetric health institution, private Medicine, Surgery, Obstetric health institution, public Follow-up and Rehabilitation Care institution, private Follow-up and Rehabilitation Care institution, medico-social institution, town professionals and user associations.
* ARRPAC professionals: the 14 ARRPAC professionals involved in the day care centre will be interviewed in a semi-structured manner
Exclusion Criteria
* Persons deprived of their liberty by a judicial or administrative decision
* Persons under psychiatric care
* Persons admitted to a health or social establishment for purposes other than research
* Persons of full age subject to a legal protection measure (guardian, curators)
* Persons not affiliated to a social security scheme or beneficiaries of a similar scheme
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Accueil de jour ARRPAC
Bron, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL22_0638
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.